Cite
MLA Citation
Thomas Urup et al.. “Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients.” Molecular oncology, vol. 10, no. 8, n.d., pp. 1160–1168. http://access.bl.uk/ark:/81055/vdc_100045419828.0x00004d